J. Bailey

发表

The effects of idazoxan on reaction times, eye movements and the mood of healthy volunteers and patients with upper respiratory tract illnesses

Andrew P. Smith, D. Nutt, Sue J. Wilson, 1999, Journal of psychopharmacology.

The effects of 7.5% carbon dioxide inhalation on task performance in healthy volunteers

D. Nutt, M. Munafo, E. Farmer, 2012, Journal of Psychopharmacology.

Sedative antidepressants impair visual detection mechanisms in humans

D. Nutt, D. Nutt, S. Wilson, 1996, Journal of psychopharmacology.

Inhalation of 35% CO2 results in activation of the HPA axis in healthy volunteers

D. Nutt, S. Argyropoulos, S. Lightman, 2002, Psychoneuroendocrinology.

Effects of 5 weeks of administration of fluoxetine and dothiepin in normal volunteers on sleep, daytime sedation, psychomotor performance and mood

D. Nutt, S. Wilson, A. Weinstein, 2002, Journal of psychopharmacology.

An investigation of effects of fluvoxamine and dothiepin on sleep and daytime sleepiness in normal volunteers

D. Nutt, S. Wilson, C. Alford, 1994, European Neuropsychopharmacology.

GABA-A receptors and the response to CO2 inhalation — A translational trans-species model of anxiety?

D. Nutt, J. Bailey, 2008, Pharmacology Biochemistry and Behavior.

Preliminary evidence of anxiolytic effects of the CRF1 receptor antagonist R317573 in the 7.5% CO2 proof-of-concept experimental model of human anxiety

G. Dawson, D. Nutt, C. Dourish, 2011, Journal of psychopharmacology.

Imagery of craving in opiate addicts undergoing detoxification.

D. Nutt, S. Wilson, A. Weinstein, 1997, Drug and alcohol dependence.

The 5-HT3 antagonist ondansetron reduces gastrointestinal side effects induced by a specific serotonin re-uptake inhibitor in man

D. Nutt, N. Coupland, J. Potokar, 1995, Journal of psychopharmacology.

The Application of Good Clinical Practice to Challenge Tests

J. Bailey, 2004, Journal of psychopharmacology.

The feasibility of abrupt methadone‐buprenorphine transfer in British opiate addicts in an outpatient setting

F. Law, J. Melichar, J. Lewis, 1997, Addiction biology.

A pharmacodynamic study of the α2‐adrenergic receptor antagonist ethoxyidazoxan in healthy volunteers

D. Nutt, Sue J. Wilson, W. Potter, 1994, Clinical pharmacology and therapeutics.

A comparison of the effects of a subtype selective and non-selective benzodiazepine receptor agonist in two CO2 models of experimental human anxiety

A. Papadopoulos, J. Bailey, D. Nutt, 2009, Journal of psychopharmacology.

Cardiovascular reflexes during treatment of social phobia with moclobemide

D. Nutt, C. Bell, N. Coupland, 2001 .

Changes in cardiovascular function after venlafaxine but not pregabalin in healthy volunteers: a double‐blind, placebo‐controlled study of orthostatic challenge, blood pressure and heart rate

D. Nutt, G. Dawson, Sue J. Wilson, 2013, Human psychopharmacology.

Effects of the common cold on subjective alertness, reaction time and eye movements

Andrew P. Smith, D. Nutt, Sue J. Wilson, 1999 .

Abuse of Buprenorphine in the United States

G. Woody, Meredith Y. Smith, H. Kleber, 2007, Journal of addictive diseases.

Effects on sleep architecture of pindolol, paroxetine and their combination in healthy volunteers

D. Nutt, Sue J. Wilson, C. Bell, 2003, Psychopharmacology.

RAPID COMMUNICATIONS Abuse of Buprenorphine in the United States: 2003-2005

G. Woody, Meredith Y. Smith, H. Kleber, 2008 .

The effect of a clinically effective and non‐effective dose of lorazepam on 7.5% CO2‐induced anxiety

D. Nutt, G. Dawson, A. Rich, 2012, Human psychopharmacology.

A validation of the 7.5% CO2 model of GAD using paroxetine and lorazepam in healthy volunteers

D. Nutt, J. Potokar, A. Kendrick, 2007, Journal of psychopharmacology.

Flumazenil in alcohol withdrawal: a double-blind placebo-controlled study.

A. Malizia, S. Wilson, P. Glue, 1997, Alcohol and alcoholism.

Effects of 7.5% carbon dioxide inhalation on anxiety and mood in cigarette smokers

M. Munafo, A. Attwood, S. Lightman, 2014, Journal of psychopharmacology.

Validating the inhalation of 7.5% CO2 in healthy volunteers as a human experimental medicine: a model of generalized anxiety disorder (GAD)

G. Dawson, D. Nutt, C. Dourish, 2011, Journal of psychopharmacology.

Effects of 7.5% CO2 challenge in generalized anxiety disorder

D. Nutt, Sue J. Wilson, A. Rich, 2011, Journal of psychopharmacology.

Does the Brain Noradrenaline Network Mediate the Effects of the CO2 Challenge? Reply to Reviewers' Comments

S. Lightman, J. Bailey, D. Nutt, 2003 .

Does the Brain Noradrenaline Network Mediate the Effects of the CO2 Challenge?

D. Nutt, S. Argyropoulos, S. Lightman, 2003, Journal of psychopharmacology.

Behavioral and cardiovascular effects of 7.5% CO2 in human volunteers

D. Nutt, S. Argyropoulos, David J. Nutt, 2005, Depression and anxiety.

Integrating the cognitive and physiological aspects of craving

A Malizia, D J Nutt, D. Nutt, 1998, Journal of psychopharmacology.

The effects of clonidine on cardiovascular responses to standing in healthy volunteers

D. Nutt, S. Wilson, N. Coupland, 1995, Clinical Autonomic Research.

d-Cycloserine and performance under different states of anxiety in healthy volunteers

A. Lingford-Hughes, A. Papadopoulos, J. Bailey, 2007, Psychopharmacology.

The use of sleep measures to compare a new 5HT1A agonist with buspirone in humans

D. Nutt, Sue J. Wilson, J. Nash, 2005, Journal of psychopharmacology.

Effects of 7.5% CO2 inhalation on allocation of spatial attention to facial cues of emotional expression

C. Benton, D. Nutt, M. Munafo, 2011, Cognition & emotion.

Sleep and daytime sleepiness the next day following single night-time dose of fluvoxamine, dothiepin and placebo in normal volunteers

D. Nutt, S. Wilson, C. Alford, 2000, Journal of psychopharmacology.

The cardiovascular and subjective effects of thyrotropin releasing hormone (TRH) and a stable analogue, dimethyl proline-TRH, in healthy volunteers.

P. Glue, N. Coupland, J. Bailey, 1995, British journal of clinical pharmacology.

Using sleep to evaluate comparative serotonergic effects of paroxetine and citalopram

D. Nutt, S. Wilson, A. Rich, 2004, European Neuropsychopharmacology.

Dizziness produced by a potent 5HT1A receptor agonist (eptapirone) is not due to postural hypotension

S. Wilson, J. Bailey, D. Nutt, 2005, Psychopharmacology.

A comparison of the effects of phenelzine treatment with moclobemide treatment on cardiovascular reflexes

D. Nutt, S. Wilson, N. Coupland, 1995, International clinical psychopharmacology.

Evaluation of the effects of venlafaxine and pregabalin on the carbon dioxide inhalation models of Generalised Anxiety Disorder and panic

G. Dawson, D. Nutt, A. Rich, 2013, Journal of psychopharmacology.

Thyrotropin-releasing hormone selectively reverses lorazepam-induced sedation but not slowing of saccadic eye movements.

D. Nutt, A. Hudson, S. Wilson, 1992, Life sciences.

Flumazenil in alcohol withdrawal.

S. Wilson, P. Glue, N. Coupland, 1993, Alcohol and alcoholism (Oxford, Oxfordshire). Supplement.

Thyrotropin-releasing hormone: A potential comparator for the panicogenic effects of pentagastrin and CCK?

D. Nutt, A. Malizia, N. Coupland, 1996, Biological Psychiatry.

Effects of 7.5% CO2-Induced Anxiety on Individual Performance During a Group Computer Combat Game

D. Nutt, M. Munafo, E. Farmer, 2013 .